Organon & Co (OGN)
19.18
+0.35
(+1.86%)
USD |
NYSE |
May 02, 13:26
Organon Total Long Term Debt (Quarterly): 8.76B for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.76B |
| September 30, 2023 | 8.654B |
| June 30, 2023 | 8.73B |
| March 31, 2023 | 8.711B |
| December 31, 2022 | 8.913B |
| September 30, 2022 | 8.699B |
| June 30, 2022 | 8.893B |
| March 31, 2022 | 9.094B |
| Date | Value |
|---|---|
| December 31, 2021 | 9.134B |
| September 30, 2021 | 9.298B |
| June 30, 2021 | 9.348B |
| March 31, 2021 | 1.52B |
| December 31, 2020 | 1.339B |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
9.348B
Maximum
Jun 2021
6.318B
Average
8.720B
Median
Total Long Term Debt (Quarterly) Benchmarks
| Merck & Co Inc | 0.00 |
| Alnylam Pharmaceuticals Inc | 1.021B |
| Amgen Inc | 64.61B |
| Biogen Inc | 6.540B |
| Pacira BioSciences Inc | 522.44M |